The company stated that its flu vaccine had generated a stronger immune response against all four A and B strains of the virus compared to traditional flu shots in a late-stage trial. Moderna also announced it was scaling down manufacturing of its COVID-19 vaccine, an updated version of which was approved this week by U.S. regulators, to align with lower post-pandemic demand and help the company sooner hit its target of 75% to 80% gross margin growth.
Tag Archive for: COVID-19 vaccine
China’s CanSino Biologics, which recently announced a contract manufacturing deal to support AstraZeneca’s messenger RNA (mRNA) technology vaccine program, is in talks with more firms on similar deals, its CEO said, as it seeks new revenue streams to make up for plummeting COVID vaccine demand.
The European Medicines Agency (EMA) said on Wednesday its human medicines committee (CHMP) recommended authorizing Pfizer’s updated COVID-19 vaccine targeting the dominant XBB.1.5 variant of Omicron.
Pfizer and German partner BioNTech on Monday asked the U.S. Patent and Trademark Office to reconsider, and ultimately invalidate, Moderna’s patents over core technologies of the COVID-19 vaccine, Reuters reported.
AstraZeneca is facing two London lawsuits, including one from the husband of a woman who died after receiving the Anglo-Swedish drugmaker’s COVID-19 vaccine, in the first of potentially dozens of cases brought in England.
Advisers to the U.S. Food and Drug Administration on Thursday will discuss and vote on whether to recommend targeting one of the currently dominant XBB coronavirus variants in updated COVID-19 shots being developed for a fall vaccination campaign.
The first hearing in a German court case against BioNTech over side effects allegedly caused by its COVID-19 vaccine was postponed on Monday after the plaintiff’s lawyer petitioned for the case to be heard by different judges.
The company said it filed a counterclaim alleging that Pfizer and its German partner BioNTech infringed on nine of its patents, broader than its original claim of three patents.
Moderna Inc. on Thursday reported a surprise profit and stronger-than-expected sales for its COVID-19 vaccine in the first quarter, as it received payments for orders that were deferred last year.
Pfizer Inc. has pledged to deliver critical new medicines more quickly in low-income nations, but its first such vaccine effort faces hurdles likely to delay distribution in poorer countries by several years, global health officials told Reuters.
